Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)
16.91
+0.31 (1.87%)
Apr 25, 2025, 10:45 AM CST
SHE:300233 Revenue
In the year 2024, Shandong Jincheng Pharmaceutical Group had annual revenue of 3.37B CNY, down -4.66%. Shandong Jincheng Pharmaceutical Group had revenue of 858.07M in the quarter ending December 31, 2024, a decrease of -11.50%.
Revenue
3.37B
Revenue Growth
-4.66%
P/S Ratio
1.90
Revenue / Employee
922.45K
Employees
3,657
Market Cap
6.40B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.37B | -164.93M | -4.66% |
Dec 31, 2023 | 3.54B | 32.60M | 0.93% |
Jan 1, 2023 | 3.51B | 367.26M | 11.70% |
Jan 1, 2022 | 3.14B | 176.52M | 5.96% |
Dec 31, 2020 | 2.96B | 167.12M | 5.98% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Wanhua Chemical Group | 178.98B |
Baoshan Iron & Steel | 332.34B |
Shandong Gold Mining | 82.52B |
Ningxia Baofeng Energy Group | 35.53B |
Hengli Petrochemical | 235.00B |
Qinghai Salt Lake Industry Co.,Ltd | 15.13B |
China Northern Rare Earth (Group) High-Tech Co.,Ltd | 32.97B |
Inner Mongolia Baotou Steel Union | 68.09B |